GREY:IMVIQ - Post by User
Comment by
Breakthorough1on Feb 08, 2023 2:16am
272 Views
Post# 35273619
RE:RE:meeting with management
RE:RE:meeting with managementeurope10, just one thing:
19'9 months mOS (compare with the 16 months of mirvetuximab -ImmunoGen-, and these only among tbe high-falpha patients) and 50% alive after 24 months in ovarian ARE staggering results indeed.
The problem is that to have OS data you need to wait at least a couple of years, while to have ORR data (not staggering for Mvp-S, true) you need about just a year. The problem is timing.